Original disclosure @ EIB website
Updated in EWS Feb 20, 2023
Disclosed by Bank Feb 9, 2023
Can you contribute information about this project?
Contact the EWS Team
According to the EIB's disclosure, the project concerns a quasi-equity financing to Icosagen AS, an Estonian biotech developing innovative solutions in the discovery, development and manufacturing of biopharmaceuticals.
The operation will support Icosagen's investments into research, development and innovation, as well as clinical, manufacturing and regulatory costs for its current good manufacturing practice site. Other research drug development programmes are also included in the project.
From the EIB's website:
Icosagen, founded in 1999 to provide molecular diagnostics services to Estonian medical institutions, provides contract research services to the biopharma/ biotech industries and academia to support the development of biologic drugs. The company offers a catalog of off-the-shelf products, such as antibodies, proteins, and ELISA kits.
|Private Actor 1||Private Actor 1 Role||Private Actor 1 Sector||Relation||Private Actor 2||Private Actor 2 Role||Private Actor 2 Sector|
|-||-||-||-||Icosagen AS||Client||Education and Health|
Client - Icosagen AS:
- EU: Eerika tee 1, Õssu, Kambja vald, Tartu maakond 61713, Estonia
- USA: 77 Geary St. 5th Floor, San Francisco, CA 94108
Phone: +372 737 7070 (EU) ; +1 415 548 6625 (USA)
ACCESS TO INFORMATION
You can submit an information request for project information at: https://www.eib.org/en/infocentre/registers/request-form/request-form-default.htm
ACCOUNTABILITY MECHANISM OF EIB
The EIB Complaints Mechanism is designed to facilitate and handle complaints against the EIB by individuals, organizations or corporations affected by EIB activities. When exercising the right to lodge a complaint against the EIB, any member of the public has access to a two-tier procedure, one internal - the Complaints Mechanism Office - and one external - the European Ombudsman. A complaint can be lodged via a written communication addressed to the Secretary General of the EIB, via email to the dedicated email address: email@example.com, by completing the online complaint form available at the following address: http://www.eib.org/complaints/form via fax or delivered directly to the EIB Complaints Mechanism Division, any EIB local representation office or any EIB staff. For further details, check: http://www.eib.org/attachments/strategies/complaints_mechanism_policy_en.pdf
When dissatisfied with a complaint to the EIB Complaints Mechanism, citizens can then turn towards the European Ombudsman. A memorandum of Understanding has been signed between the EIB and the European Ombudsman establishes that citizens (even outside of the EU if the Ombudsman finds their complaint justified) can turn towards the Ombudsman on issues related to 'maladministration' by the EIB. Note that before going to the Ombudsman, an attempt must be made to resolve the case by contacting the EIB. In addition, the complaint must be made within two years of the date when the facts on which your complaint is based became known to you. You can write to the Ombudsman in any of the languages of the European Union. Additional details, including filing requirements and complaint forms, are available at: http://www.ombudsman.europa.eu/atyourservice/interactiveguide.faces